Cortesia Pharma Private Limited
About Cortesia Pharma Private Limited
Data last updated:
Cortesia Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 02 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24304TN2017PTC120868.
The company has an authorised share capital of ₹260.5 Cr and a paid-up capital of ₹253.08 Cr. It is led by directors Dattatraya Narayan Dhavalikar and Godrej Baman Irani.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024.
As per the financials filed for FY 2025, the company reported a revenue of ₹57,870. For the same year it recorded a net loss of ₹2 Cr and EBITDA of -₹2 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Cortesia Pharma has one previous CIN (Corporate Identification Number): U24304PN2017PTC171802. The current CIN is U24304TN2017PTC120868, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24304TN2017PTC120868 | Current |
| U24304PN2017PTC171802 | Previous |
Contact details
Cortesia Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Cortesia Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cortesia Pharma Private Limited
FY 2025 filings availableCortesia Pharma Private Limited reported revenue of ₹57,870 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cortesia Pharma Private Limited, buy the company report.
Board of directors of Cortesia Pharma Private Limited
Cortesia Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dattatraya Narayan Dhavalikar Also directs: Magic-Square Hospitality Services LLP, Serene Productions LLP, Poonawalla Biotech Private Limited and 5 more | Director | 02 Aug 2017 | 9 Years 2 Months | Current |
| Godrej Baman Irani Also directs: Sunirudha Pharma Private Limited, Jivkalpa Pharma Private Limited, Fortune Intercontinental Private Limited and 3 more | Director | 02 Aug 2017 | 9 Years 2 Months | Current |
Peer comparison
Cortesia Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nirmaya Laboratories Private Limited | ₹60,199 (FY 2025) | Vadodara, Gujarat, India | ||||
| Modern Fastners Pvt Ltd | ₹60,000 (FY 2025) | Chandigarh, India | ||||
| Nubiotic Pharmaceuticals Private Limited | ₹59,207 (FY 2021) | -57.0% | Patna, Bihar, India | |||
| Hindustan Bio-Tech- Limited | ₹59,000 (FY 2022) | -28.0% | Ahmedabad, Gujarat, India | |||
| Reelox Pharmaceutical Private Limited | ₹58,441 (FY 2021) | 330.0% | Kushi Nagar, Uttar Pradesh, India | |||
| Cortesia Pharma Private Limitedthis company | ₹57,870 (FY 2025) | -₹2 Cr | Chennai, Tamil Nadu, India | |||
| Getwell Oncology Private Limited | ₹57,377 (FY 2024) | 258.0% | Delhi, India | |||
| Nexlife Bioscience Private Limited | ₹56,820 (FY 2025) | 2.0% | Ahmedabad, Gujarat, India | |||
| Vemed Pharmaceuticals Private Limited | ₹56,676 (FY 2024) | Vadodara, Gujarat, India | ||||
| S K Poly Formulations Private Limited | ₹56,624 (FY 2024) | 41.0% | Thane, Maharashtra, India | |||
| Septem Pharmaceuticals Private Limited | ₹55,462 (FY 2025) | -96.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Cortesia Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cortesia Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cortesia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cortesia Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cortesia Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Dattatraya Narayan Dhavalikar was appointed as Director on 02 Aug 2017.
Frequently asked questions
Cortesia Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 02 August 2017 (9+ years old) and is registered under CIN U24304TN2017PTC120868.
Cortesia Pharma has 2 current directors:
- Dattatraya Narayan Dhavalikar - Director
- Godrej Baman Irani - Director
The latest financial statements of Cortesia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Cortesia Pharma is U24304TN2017PTC120868. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cortesia Pharma was incorporated on 02 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Cortesia Pharma by revenue are Nirmaya Laboratories Private Limited, Modern Fastners Pvt Ltd, Nubiotic Pharmaceuticals Private Limited, Hindustan Bio-Tech- Limited, Reelox Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations).
Dattatraya Narayan Dhavalikar was appointed as Director on 02 Aug 2017. Godrej Baman Irani was appointed as Director on 02 Aug 2017.
The registered office of Cortesia Pharma is at 13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024.
Cortesia Pharma operates in the food and beverages industry, in the artificial fibres segment.
The compliance status of Cortesia Pharma is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.
Cortesia Pharma can be reached at its registered office: 13 Old No 5 A – 3 Sai Niketan Circular Road United India Colony Kodambakkam, Chennai, Tamil Nadu, India – 600024.